Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis
Objectives: To evaluate whether proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9i) is associated with cardiovascular and safety events in statin-treated patients with cardiovascular risk. Methods: Electronic databases (Pubmed, Cochrane, MEDLINE, EMBASE, ClinicalTrials.gov) were searche...
| Autors principals: | , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Frontiers Media S.A.
2020-10-01
|
| Col·lecció: | Journal of Pharmacy & Pharmaceutical Sciences |
| Accés en línia: | https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31197 |